Cargando…

A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine

BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jian-Feng, Chen, Wen, Huang, Su-Yu, Ye, Jian-Liang, Huang, Pei-Qiang
Formato: Texto
Lenguaje:English
Publicado: Beilstein-Institut 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200668/
https://www.ncbi.nlm.nih.gov/pubmed/17996045
http://dx.doi.org/10.1186/1860-5397-3-41
_version_ 1782148297061826560
author Zheng, Jian-Feng
Chen, Wen
Huang, Su-Yu
Ye, Jian-Liang
Huang, Pei-Qiang
author_facet Zheng, Jian-Feng
Chen, Wen
Huang, Su-Yu
Ye, Jian-Liang
Huang, Pei-Qiang
author_sort Zheng, Jian-Feng
collection PubMed
description BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, filters, lenses of variable optical density, and photomechanical biomaterials etc. And (1R,8aS)-1-hydroxyindolizidine (3) has been postulated to be a biosynthetic precursor of hydroxylated indolizidines such as (+)-lentiginosine 1, (−)-2-epilentiginosine 2 and (−)-swainsonine, which are potentially useful antimetastasis drugs for the treatment of cancer. In continuation of a project aimed at the development of enantiomeric malimide-based synthetic methodology, we now report a divergent, concise and highly diastereoselective approach for the asymmetric syntheses of an aza-spiropyran derivative 7 and (1S,8aR)-1-hydroxyindolizidine (ent-3). RESULTS: The synthesis of aza-spiropyran 7 started from the Grignard addition of malimide 4. Treatment of the THP-protected 4-hydroxybutyl magnesium bromide with malimide 4 at −20°C afforded N,O-acetal 5a as an epimeric mixture in a combined yield of 89%. Subjection of the diastereomeric mixture of N,O-acetal 5a to acidic conditions for 0.5 h resulted in the formation of the desired functionalized aza-spiropyran 7 as a single diastereomer in quantitative yield. The stereochemistry of the aza-spiropyran 7 was determined by NOESY experiment. For the synthesis of ent-3, aza-spiropyran 7, or more conveniently, N,O-acetal 5a, was converted to lactam 6a under standard reductive dehydroxylation conditions in 78% or 77% yield. Reduction of lactam 6a with borane-dimethylsulfide provided pyrrolidine 8 in 95% yield. Compound 8 was then converted to 1-hydroxyindolizidine ent-3 via a four-step procedure, namely, N-debenzylation/O-mesylation/Boc-cleavage/cyclization, and O-debenzylation. Alternatively, amino alcohol 8 was mesylated and the resultant mesylate 12 was subjected to hydrogenolytic conditions, which gave (1S,8aR)-1-hydroxyindolizidine (ent-3) in 60% overall yield from 8. CONCLUSION: By the reaction of functionalized Grignard reagent with protected (S)-malimide, either aza-spiropyran or (1S,8aR)-1-hydroxyindolizidine skeleton could be constructed in a concise and selective manner. The results presented herein constitute an important extension of our malimide-based synthetic methodology.
format Text
id pubmed-2200668
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-22006682008-01-16 A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine Zheng, Jian-Feng Chen, Wen Huang, Su-Yu Ye, Jian-Liang Huang, Pei-Qiang Beilstein J Org Chem Full Research Paper BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, filters, lenses of variable optical density, and photomechanical biomaterials etc. And (1R,8aS)-1-hydroxyindolizidine (3) has been postulated to be a biosynthetic precursor of hydroxylated indolizidines such as (+)-lentiginosine 1, (−)-2-epilentiginosine 2 and (−)-swainsonine, which are potentially useful antimetastasis drugs for the treatment of cancer. In continuation of a project aimed at the development of enantiomeric malimide-based synthetic methodology, we now report a divergent, concise and highly diastereoselective approach for the asymmetric syntheses of an aza-spiropyran derivative 7 and (1S,8aR)-1-hydroxyindolizidine (ent-3). RESULTS: The synthesis of aza-spiropyran 7 started from the Grignard addition of malimide 4. Treatment of the THP-protected 4-hydroxybutyl magnesium bromide with malimide 4 at −20°C afforded N,O-acetal 5a as an epimeric mixture in a combined yield of 89%. Subjection of the diastereomeric mixture of N,O-acetal 5a to acidic conditions for 0.5 h resulted in the formation of the desired functionalized aza-spiropyran 7 as a single diastereomer in quantitative yield. The stereochemistry of the aza-spiropyran 7 was determined by NOESY experiment. For the synthesis of ent-3, aza-spiropyran 7, or more conveniently, N,O-acetal 5a, was converted to lactam 6a under standard reductive dehydroxylation conditions in 78% or 77% yield. Reduction of lactam 6a with borane-dimethylsulfide provided pyrrolidine 8 in 95% yield. Compound 8 was then converted to 1-hydroxyindolizidine ent-3 via a four-step procedure, namely, N-debenzylation/O-mesylation/Boc-cleavage/cyclization, and O-debenzylation. Alternatively, amino alcohol 8 was mesylated and the resultant mesylate 12 was subjected to hydrogenolytic conditions, which gave (1S,8aR)-1-hydroxyindolizidine (ent-3) in 60% overall yield from 8. CONCLUSION: By the reaction of functionalized Grignard reagent with protected (S)-malimide, either aza-spiropyran or (1S,8aR)-1-hydroxyindolizidine skeleton could be constructed in a concise and selective manner. The results presented herein constitute an important extension of our malimide-based synthetic methodology. Beilstein-Institut 2007-11-08 /pmc/articles/PMC2200668/ /pubmed/17996045 http://dx.doi.org/10.1186/1860-5397-3-41 Text en Copyright © 2007, Zheng et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)
spellingShingle Full Research Paper
Zheng, Jian-Feng
Chen, Wen
Huang, Su-Yu
Ye, Jian-Liang
Huang, Pei-Qiang
A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title_full A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title_fullStr A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title_full_unstemmed A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title_short A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
title_sort divergent asymmetric approach to aza-spiropyran derivative and (1s,8ar)-1-hydroxyindolizidine
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200668/
https://www.ncbi.nlm.nih.gov/pubmed/17996045
http://dx.doi.org/10.1186/1860-5397-3-41
work_keys_str_mv AT zhengjianfeng adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT chenwen adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT huangsuyu adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT yejianliang adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT huangpeiqiang adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT zhengjianfeng divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT chenwen divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT huangsuyu divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT yejianliang divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine
AT huangpeiqiang divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine